GEHCGE HealthCare

$73.31

$59.4952 weeks$88.08

Price

$73.31+4.9%1Y

1M+18%1Y+4.9%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Top tier

9/10

Value67

Quality89

Momentum44

Growth51

Strongest Quality, weakest Momentum · ranked vs Healthcare peers. The five questions below judge the company on its own terms.

What they do

GE HealthCare Technologies Inc. (“GE HealthCare,” the “Company,” “our,” “us,” or “we”) is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle the world’s most complex diseases. We have approximately 54,000 colleagues dedicated to our purpose to create a world where healthcare has no limits. Serving patients and providers for nearly 130 years, GE HealthCare is delivering bold innovations designed for the next era of medicine to help clinicians deliver more personalized, precise patient care.

In the company’s own words · 10-K filed Feb 4, 2026 · SEC EDGAR

P/E (TTM)17.5

Market Cap$28.02B

1Y Return+4.9%

5Y Return-

Business segments

Q2 2026 · $3.73B

The company’s own SEC segment disclosure.

AIS$2.39B64%
P Dx$843.0M23%
PCS$503.0M13%

GE HealthCare (GEHC) reported revenue of $5.13B in Q1 2026 (quarter ended March 31, 2026), up 7.4% from the same quarter a year earlier. That came with a gross margin of 39% and net income of $389M (7.6% of revenue). For the full year FY2025, revenue was $20.6B (+4.8% year on year) and net income $2.08B. Its largest segment in 2026-Q2 was AIS at $2.39B, 64% of the disclosed total, just ahead of P Dx at 23%.

Raw charts

11 series · TTM

As reported to the SEC, without any scoring.

Medical Devices

Ranks #5 of 35 by Smart Score